Guangzhou, China

Xiaoqu Hu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Inventor Xiaoqu Hu

Introduction

Xiaoqu Hu is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of cancer therapeutics through his innovative research and patents. His work focuses on targeting cancer stem cells, which are crucial in the development and progression of various cancers.

Latest Patents

Xiaoqu Hu holds a patent titled "Let-7 microRNA and mimetics thereof as therapeutics for cancer." This invention relates to methods for treating or preventing cancers by targeting cancer stem cells. Specifically, it involves administering miRNAs that are either reduced or lacking in cancer stem cells, particularly let-7 miRNAs. The patent also explores methods to enrich cancer stem cell populations and identify miRNAs that contribute to their self-renewal capacity. He has 1 patent to his name.

Career Highlights

Xiaoqu Hu is associated with the Children's Medical Center Corporation, where he continues to advance his research in cancer treatment. His innovative approaches have the potential to revolutionize how cancers are treated, offering new hope for patients.

Collaborations

Throughout his career, Xiaoqu Hu has collaborated with notable researchers, including Judy Lieberman and Erwei Song. These collaborations have further enriched his research and contributed to the development of effective cancer therapies.

Conclusion

Xiaoqu Hu's work in cancer therapeutics exemplifies the impact of innovative research on medical science. His patent on let-7 microRNA highlights the importance of targeting cancer stem cells in treatment strategies. His contributions are paving the way for future advancements in cancer care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…